# Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)

> **NCT00454662** · PHASE4 · COMPLETED · sponsor: **COLM Study Research Organization** · enrollment: 5141 (actual)

## Conditions studied

- Hypertension
- Cardiovascular Disease
- Diabetes

## Interventions

- **DRUG:** olmesartan medoxomil / amlodipine or azelnidipine
- **DRUG:** olmesartan medoxomil / low dose thiazide type drug

## Key facts

- **NCT ID:** NCT00454662
- **Lead sponsor:** COLM Study Research Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 5141 (ACTUAL)
- **Last updated:** 2013-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454662, "Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00454662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*